Regular RELIABLE pricing discount information (For all European Markets)
- Discount levels per brand in each market
- Range of value added features and incentives that enhance the offer and contribute to overall "price"
The Reality - Extensive and significant pricing discounts are being applied to the European Hospital Market, meaning understanding the impact of Market Access for drugs and the traditional method of cashing out the European Hospital Expenditure is clearly somewhat inaccurate and flawed.
There is a significant requirement for a reliable, regular data source on insights into “real world” prices paid (typical discount levels offered to hospitals) on key pharmaceutical products, including other influencing factors.
Due to its personnel’s experience of previous price tracking studies within the European hospital sector, Next Research has been request by various clients to provide a statistically reliable, regular price tracking service which offers companies access to this critical, highly significant insights. Now Next Research would like to offer this data in a syndicated form.
Providing, syndicated and primary Quantitative reports of various discount levels (average, highest, lowest etc) in addition to qualitative aspects such as other influencing factors outside of price, such as opinions, stocking preference and the reasons why for choice etc.
The Average discounts – Net Price (%) for Therapy area A. Read more >>
A Comparison of Average discounts (%) across Therapy Area D. Read more >>
We examine average discounts Overall (%) Therapy Area D by Brand for Germany. Read more >>
We examine what percentage of the total discount (%) was from Government tender for Therapy Area D by Brand. Read more >>
We examine the progression of the dynamic discounts between 2 waves of data for average discounts (%) for Therapy Area A products by Brand for the Top % 5 EU countries. Read more >>
We examine the distribution of Average Discounts (%) by Length of Contract for each therapy area monitored in the PIM for top 5 EU countries. Read more >>
We examine best competitor performance. Read more >>